ES437259A1 - Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental. - Google Patents

Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental.

Info

Publication number
ES437259A1
ES437259A1 ES437259A ES437259A ES437259A1 ES 437259 A1 ES437259 A1 ES 437259A1 ES 437259 A ES437259 A ES 437259A ES 437259 A ES437259 A ES 437259A ES 437259 A1 ES437259 A1 ES 437259A1
Authority
ES
Spain
Prior art keywords
carbon atoms
alkyl
phenyl
alkoxy
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES437259A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES437259A1 publication Critical patent/ES437259A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/562Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with nitrogen as the only hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
ES437259A 1973-03-01 1975-04-30 Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental. Expired ES437259A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US336919A US3878225A (en) 1973-03-01 1973-03-01 Condensed pyrroles bearing an N-phenyl substituent

Publications (1)

Publication Number Publication Date
ES437259A1 true ES437259A1 (es) 1977-01-01

Family

ID=23318274

Family Applications (2)

Application Number Title Priority Date Filing Date
ES423562A Expired ES423562A1 (es) 1973-03-01 1974-02-23 Procedimiento para la preparacion de nuevos n-fenilpirro- les.
ES437259A Expired ES437259A1 (es) 1973-03-01 1975-04-30 Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES423562A Expired ES423562A1 (es) 1973-03-01 1974-02-23 Procedimiento para la preparacion de nuevos n-fenilpirro- les.

Country Status (20)

Country Link
US (1) US3878225A (es)
JP (1) JPS6139304B2 (es)
AT (1) AT332389B (es)
BE (1) BE811785A (es)
CA (1) CA1025455A (es)
CH (1) CH611605A5 (es)
CS (1) CS191225B2 (es)
DE (1) DE2407671C2 (es)
ES (2) ES423562A1 (es)
FI (1) FI61183C (es)
FR (1) FR2219790B1 (es)
GB (1) GB1457601A (es)
HU (1) HU170834B (es)
IE (1) IE38943B1 (es)
IL (1) IL44279A (es)
NL (1) NL177828C (es)
NO (1) NO142346C (es)
SE (1) SE397523B (es)
SU (1) SU610488A3 (es)
ZA (1) ZA741333B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056624A (en) * 1976-05-14 1977-11-01 American Hoechst Corporation Method of treating dermal inflammation
US4929622A (en) * 1987-09-24 1990-05-29 Hoechst-Roussel Pharmaceuticals, Inc. 2,6-Methanopyrrolo-3-benzazocines
US5145965A (en) * 1987-09-24 1992-09-08 Hoechst-Roussel Pharmaceuticals Incorporated 2,6-methanopyrrolo-3-benzazocines
US4814501A (en) * 1987-12-28 1989-03-21 Merck & Co., Inc. Process for preparing N,N-dimethyl 2-(methylthio) benzamides and analogs
US9216966B2 (en) 2004-10-04 2015-12-22 John Manfredi Compounds for Alzheimer's disease
CA2582674A1 (en) * 2004-10-04 2006-04-20 Myriad Genetics, Inc. Compounds for alzheimer's disease
US7678823B2 (en) 2004-10-04 2010-03-16 Myriad Pharmaceticals, Inc. Compounds for alzheimer's disease
AU2007234399A1 (en) * 2006-04-04 2007-10-11 Myriad Genetics, Inc. Compounds for diseases and disorders
KR20100046107A (ko) * 2007-07-24 2010-05-06 아스텔라스세이야쿠 가부시키가이샤 벤즈이미다졸 유도체
PL2276732T3 (pl) 2008-04-16 2015-11-30 Karobio Ab Nowe ligandy receptora estrogenowego
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD70880A (es) *
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
GB1351754A (en) * 1970-07-02 1974-05-01 Allen & Hanburys Ltd Indenopyrrole derivatives

Also Published As

Publication number Publication date
IE38943B1 (en) 1978-07-05
NO142346C (no) 1980-08-06
IE38943L (en) 1974-09-01
FI61183B (fi) 1982-02-26
ES423562A1 (es) 1976-06-01
US3878225A (en) 1975-04-15
JPS6139304B2 (es) 1986-09-03
AT332389B (de) 1976-09-27
ATA165474A (de) 1976-01-15
JPS49134671A (es) 1974-12-25
GB1457601A (en) 1976-12-08
ZA741333B (en) 1975-02-26
AU6618874A (en) 1975-09-04
NO142346B (no) 1980-04-28
FR2219790A1 (es) 1974-09-27
FR2219790B1 (es) 1978-09-22
SE397523B (sv) 1977-11-07
SU610488A3 (ru) 1978-06-05
NL177828C (nl) 1985-12-02
FI61183C (fi) 1982-06-10
IL44279A0 (en) 1974-05-16
NL177828B (nl) 1985-07-01
IL44279A (en) 1977-10-31
NL7402465A (es) 1974-09-03
DE2407671A1 (de) 1974-09-12
CH611605A5 (es) 1979-06-15
CS191225B2 (en) 1979-06-29
HU170834B (hu) 1977-09-28
NO740694L (no) 1974-09-03
CA1025455A (en) 1978-01-31
DE2407671C2 (de) 1983-12-01
BE811785A (fr) 1974-09-02

Similar Documents

Publication Publication Date Title
ES437259A1 (es) Procedimiento para la preparacion de una composicion admi- nistrable por via oral y parental.
AU578329B2 (en) Anti cancer treatment with porphyrins
CA1273019C (en) ENKEPHALINASE INHIBITORS
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
MY100343A (en) Amide derivative and external medicament comprising same
TR199701490A2 (xx) 3-Hidroksipiridin-2-karbonasitamidester ve bunlar�n imalat�.
EA199801017A1 (ru) Композиции для лечения заболеваний, опосредованных циклооксигеназой-2, способ лечения воспалительного заболевания
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
NO994330D0 (no) Metode for behandling av en tumor
IE832503L (en) 1,2,3,4-tetrasubstituted naphthalenes
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
SE8305157D0 (sv) Biologiskt aktiva 2,5-piperazindionderivat, sett for framstellning derav samt farmaceutiska kompositioner innehallande desamma
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
SE8304545D0 (sv) Benzamide derivatives
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
AU2143683A (en) Nitrosourea derivatives
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
IT1210926B (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
FR2433019A1 (fr) Nouveaux thiophenecarboxamidoalkylmercaptans, utiles notamment comme mucolytiques, et compositions pharmaceutiques les contenant
GB1498857A (en) Antidepressant composition
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
GB1433934A (en) Thioureas
FR2285858A1 (fr) Nouveaux composes chimiques utiles comme medicaments anti-inflammatoires et procede pour leur obtention
GB1531091A (en) Pharmaceutical combination preparations
ATE47863T1 (de) Makrolide derivate.